STT
64
2
K
51
-3
MSFT
48
-9
EL
15
-3
COST
57
-6
ISRG
71
-5
JNPR
50
-6
TXN
43
-5
CAG
24
-3
TGNA
50
-6
EOG
56
-2
THC
60
-5
EXR
57
2
KSS
39
-7
IFF
47
-4
DRI
50
-3
MAS
52
-4
D
40
2
AAP
35
-9
URBN
48
-6
STT
64
2
K
51
-3
MSFT
48
-9
EL
15
-3
COST
57
-6
ISRG
71
-5
JNPR
50
-6
TXN
43
-5
CAG
24
-3
TGNA
50
-6
EOG
56
-2
THC
60
-5
EXR
57
2
KSS
39
-7
IFF
47
-4
DRI
50
-3
MAS
52
-4
D
40
2
AAP
35
-9
URBN
48
-6
Financhill
Back

Ribbon Communications Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
38

RBBN
Ribbon Communications

Last Price:
3.90
Seasonality Move:
5.85%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
38
Ribbon Communications (RBBN) is a Sell

Is Ribbon Communications a Buy, Sell or Hold?

  • The current Ribbon Communications [RBBN] share price is $3.89. The Score for RBBN is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RBBN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RBBN Stock Price Chart

What is Ribbon Communications's stock price today?

  • The Ribbon Communications share price today is $3.89
    The current trend is moderately bullish and RBBN is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

RBBN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 56.64 Buy
Chaikin Money Flow: -147920 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.42 - 4) Buy
Bollinger Bands (100): (3.01 - 3.69) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

RBBN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.07 Sell
20-day SMA: 3.8 Buy
50-day SMA: 3.4 Buy
200-day SMA: 3.2 Buy
8-day EMA: 3.98 Sell
20-day EMA: 3.82 Buy
50-day EMA: 3.56 Buy
200-day EMA: 3.22 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Ribbon Communications Earnings Growth & RBBN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.07 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Ribbon Communications Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):